Nguyen Lam Vuong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nguyen Lam Vuong has a total of 674 co-authors. Here are the top co-authors by number of shared publications:
- Nguyen Tien Huy
Institute of Research and Development Duy Tan University Da Nang Vietnam
25 shared publications Dong Thi Hoai Tam
Oxford University Clinical Research Unit, Wellcome Trust Africa and Asia Programme, Ho Chi Minh City, Viet Nam
11 shared publicationsHuynh Thi Le Duyen
Oxford University Clinical Research Unit, Wellcome Trust Africa and Asia Programme, Ho Chi Minh City, Viet Nam
11 shared publications- Sophie Yacoub
Oxford University Clinical Research Unit
11 shared publications - Kenji Hirayama
School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan
9 shared publications Nguyen Hoang Bac
Department of General Surgery, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam
8 shared publications
Latest Publications
- Open Access
- 28 October 2026
- Published by Springer Nature in BMC Infectious Diseases
Neutrophil kinetics in dengue patients compared to other febrile illnesses: results from 6082 patients in Vietnam
Background: Neutrophils are implicated in dengue pathogenesis, yet their kinetics and association with clinical outcomes remain poorly characterized. We investigated neutrophil count trajectories and their relationship with disease severity using a large, pooled dataset from clinical studies conducted over 20 years in Vietnam. Methods: This analysis included data from 11,290 patients across nine studies (1999–2018). Patients were enrolled in outpatient settings (54.2%), at hospital admission (28.9%), or in intensive care units (16.9%). Clinical and laboratory parameters were recorded daily. Dengue was laboratory-confirmed via RT-PCR, NS1, or IgM seroconversion. Dengue shock syndrome (DSS) was defined according to WHO 1997 and 2009 criteria. Linear mixed-effects models were employed to characterize the kinetics of total white cell, neutrophil, and lymphocyte counts. Results: Among 6,082 patients with available neutrophil data, 4,071 had confirmed dengue (including 1,067 [26%] with DSS) and 2,011 had other febrile illnesses (OFI). Neutrophil and total white cell counts declined during the febrile phase, reaching a nadir on illness days 4–6. This trajectory differed significantly from lymphocytes, which reached a nadir earlier, on days 2–3. Transient neutropenia (< 1.5 K/µL) was more prevalent in uncomplicated dengue (84%) than in DSS (47%) or OFI (33%). Conclusions: Transient neutropenia is a hallmark of dengue infection, particularly in uncomplicated cases. Neutrophils follow a distinct kinetic profile compared to lymphocytes, with a significantly later nadir. These findings suggest that neutrophil dynamics are closely linked to the clinical course of dengue and warrant further mechanistic research to clarify their role in pathogenesis and recovery.
- 28 October 2026
- Published by Springer Nature in BMC Infectious Diseases
Open AccessNeutrophil kinetics in dengue patients compared to other febrile illnesses: results from 6082 patients in Vietnam
Background: Neutrophils are implicated in dengue pathogenesis, yet their kinetics and association with clinical outcomes remain poorly characterized. We investigated neutrophil count trajectories and their relationship with disease severity using a large, pooled dataset from clinical studies conducted over 20 years in Vietnam. Methods: This analysis included data from 11,290 patients across nine studies (1999–2018). Patients were enrolled in outpatient settings (54.2%), at hospital admission (28.9%), or in intensive care units (16.9%). Clinical and laboratory parameters were recorded daily. Dengue was laboratory-confirmed via RT-PCR, NS1, or IgM seroconversion. Dengue shock syndrome (DSS) was defined according to WHO 1997 and 2009 criteria. Linear mixed-effects models were employed to characterize the kinetics of total white cell, neutrophil, and lymphocyte counts. Results: Among 6,082 patients with available neutrophil data, 4,071 had confirmed dengue (including 1,067 [26%] with DSS) and 2,011 had other febrile illnesses (OFI). Neutrophil and total white cell counts declined during the febrile phase, reaching a nadir on illness days 4–6. This trajectory differed significantly from lymphocytes, which reached a nadir earlier, on days 2–3. Transient neutropenia (< 1.5 K/µL) was more prevalent in uncomplicated dengue (84%) than in DSS (47%) or OFI (33%). Conclusions: Transient neutropenia is a hallmark of dengue infection, particularly in uncomplicated cases. Neutrophils follow a distinct kinetic profile compared to lymphocytes, with a significantly later nadir. These findings suggest that neutrophil dynamics are closely linked to the clinical course of dengue and warrant further mechanistic research to clarify their role in pathogenesis and recovery.
- Open Access
- 1 July 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (7)
The Case for N-acetylcysteine in Dengue Associated Liver Injury: Time for Definitive Evidence
Dengue-associated liver injury is common, prognostically significant, and associated with high mortality at severe thresholds. Oxidative stress is a key, potentially modifiable mechanism. N-acetylcysteine has strong biological plausibility and supportive preclinical data, but clinical evidence remains limited, underscoring the need for well-designed randomized trials to inform practice and policy.
- 1 July 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (7)
Open AccessThe Case for N-acetylcysteine in Dengue Associated Liver Injury: Time for Definitive Evidence
Dengue-associated liver injury is common, prognostically significant, and associated with high mortality at severe thresholds. Oxidative stress is a key, potentially modifiable mechanism. N-acetylcysteine has strong biological plausibility and supportive preclinical data, but clinical evidence remains limited, underscoring the need for well-designed randomized trials to inform practice and policy.
- Open Access
- 9 February 2026
- Published by Public Library of Science (PLoS) in PLOS Digital Health
- Vol. 5 (2) , e0001171
Early individualized risk prediction using clinical data for children during the febrile phase of dengue in outpatient settings in Vietnam and Thailand
Dengue severity prediction models are usually developed using hospitalized patient data, but triage and hospital admission are mainly evaluated in outpatient settings. This study developed models using clinical and laboratory data from patients in outpatient settings during the febrile phase. Data from two cohort studies in Vietnam and Thailand were used to develop and validate six models: logistic regression with warning signs, Lasso-selected logistic regression, random forest, extreme gradient boosted classification, support vector machine, and artificial neural network. Models predicted dengue shock syndrome (DSS) as the primary endpoint and moderate plasma leakage and/or DSS as the secondary endpoint. We assessed model performance, discrimination, and calibration, using sensitivity, specificity, accuracy, Brier score, AUROC, CITL, calibration slope, calibration plots, and decision curve analysis. The optimal model was the Lasso-selected logistic regression for predicting DSS and the combined endpoint of moderate plasma leakage and/or DSS (Brier score: 0.044 [95% CI 0.043, 0.044] and 0.104 [95% CI 0.104, 0.105]; AUROC: 0.789 [95% CI 0.787, 0.791] and 0.741 [95% CI 0.740, 0.742]). We identified hematocrit, platelet count, lymphocyte count, and aspartate aminotransferase as predictors for DSS, and abdominal pain or tenderness, vomiting, mucosal bleeding, white blood cell count, lymphocyte count, platelet count, aspartate aminotransferase, and serum albumin as predictors for the secondary endpoint. Logistic regression and machine learning models using clinical and laboratory data during the febrile phase can support early prediction of severe disease in outpatient settings. Integrating risk prediction models into a decision support system could improve triage and optimize healthcare and resource allocation in endemic and resource-limited areas.
- 9 February 2026
- Published by Public Library of Science (PLoS) in PLOS Digital Health
- Vol. 5 (2) , e0001171
Open AccessEarly individualized risk prediction using clinical data for children during the febrile phase of dengue in outpatient settings in Vietnam and Thailand
Dengue severity prediction models are usually developed using hospitalized patient data, but triage and hospital admission are mainly evaluated in outpatient settings. This study developed models using clinical and laboratory data from patients in outpatient settings during the febrile phase. Data from two cohort studies in Vietnam and Thailand were used to develop and validate six models: logistic regression with warning signs, Lasso-selected logistic regression, random forest, extreme gradient boosted classification, support vector machine, and artificial neural network. Models predicted dengue shock syndrome (DSS) as the primary endpoint and moderate plasma leakage and/or DSS as the secondary endpoint. We assessed model performance, discrimination, and calibration, using sensitivity, specificity, accuracy, Brier score, AUROC, CITL, calibration slope, calibration plots, and decision curve analysis. The optimal model was the Lasso-selected logistic regression for predicting DSS and the combined endpoint of moderate plasma leakage and/or DSS (Brier score: 0.044 [95% CI 0.043, 0.044] and 0.104 [95% CI 0.104, 0.105]; AUROC: 0.789 [95% CI 0.787, 0.791] and 0.741 [95% CI 0.740, 0.742]). We identified hematocrit, platelet count, lymphocyte count, and aspartate aminotransferase as predictors for DSS, and abdominal pain or tenderness, vomiting, mucosal bleeding, white blood cell count, lymphocyte count, platelet count, aspartate aminotransferase, and serum albumin as predictors for the secondary endpoint. Logistic regression and machine learning models using clinical and laboratory data during the febrile phase can support early prediction of severe disease in outpatient settings. Integrating risk prediction models into a decision support system could improve triage and optimize healthcare and resource allocation in endemic and resource-limited areas.
- Top Cited PapersOpen Access
- 12 January 2026
- Published by BMJ in BMJ Public Health
- Vol. 4 (1) , e004043
Dengue therapeutics consortium 2025: a global collaboration in action
Dengue is a global health emergency, with annually increasing case numbers that overwhelm healthcare systems, an ever-expanding range of the mosquito vector, and no antiviral or host-directed treatments proven to alter the course of disease. This article reports on a meeting of the Dengue Therapeutics Consortium, which included attendees from 19 countries with backgrounds in basic science, clinical research, drug development, industry, clinical trial methodology and policy. We summarise the current state of dengue therapeutics research and highlight the necessary steps to ensure that patients have equitable access to affordable and effective treatments. We review the antiviral pipeline, including novel and repurposed antiviral candidates, and we propose both human challenge and rate of viral clearance studies as methods to rapidly screen for antiviral activity prior to larger phase 3 clinical trials. We review ongoing phase 2 and phase 3 clinical trials to evaluate repurposed host-directed therapies for patients with moderate and severe disease, and we suggest considerations for future trial design, such as factorial randomisation and the use of a core outcome set to maximise efficiency and enable evidence synthesis by meta-analysis. We consider that multisectoral collaboration will be essential to achieve our aim of effective treatments for dengue. This will include drug development aligned to target product profiles, conduct of clinical trials with endpoints acceptable to both patients and regulators and sustained commitment from the pharmaceutical industry, non-profit initiatives and policymakers to ensure that effective treatments reach those who need them the most.
- 12 January 2026
- Published by BMJ in BMJ Public Health
- Vol. 4 (1) , e004043
Top Cited PapersOpen AccessDengue therapeutics consortium 2025: a global collaboration in action
Dengue is a global health emergency, with annually increasing case numbers that overwhelm healthcare systems, an ever-expanding range of the mosquito vector, and no antiviral or host-directed treatments proven to alter the course of disease. This article reports on a meeting of the Dengue Therapeutics Consortium, which included attendees from 19 countries with backgrounds in basic science, clinical research, drug development, industry, clinical trial methodology and policy. We summarise the current state of dengue therapeutics research and highlight the necessary steps to ensure that patients have equitable access to affordable and effective treatments. We review the antiviral pipeline, including novel and repurposed antiviral candidates, and we propose both human challenge and rate of viral clearance studies as methods to rapidly screen for antiviral activity prior to larger phase 3 clinical trials. We review ongoing phase 2 and phase 3 clinical trials to evaluate repurposed host-directed therapies for patients with moderate and severe disease, and we suggest considerations for future trial design, such as factorial randomisation and the use of a core outcome set to maximise efficiency and enable evidence synthesis by meta-analysis. We consider that multisectoral collaboration will be essential to achieve our aim of effective treatments for dengue. This will include drug development aligned to target product profiles, conduct of clinical trials with endpoints acceptable to both patients and regulators and sustained commitment from the pharmaceutical industry, non-profit initiatives and policymakers to ensure that effective treatments reach those who need them the most.
- Open Access
- 19 December 2025
- Published by Elsevier in Preventive Medicine Reports
- Vol. 61
Behavioral and social drivers of rotavirus vaccine uptake in a rural ethnic minority population in Vietnam: A cross-sectional study
- 19 December 2025
- Published by Elsevier in Preventive Medicine Reports
- Vol. 61
Open AccessBehavioral and social drivers of rotavirus vaccine uptake in a rural ethnic minority population in Vietnam: A cross-sectional study
- Open Access
Clinical and immunometabolic profiles of overweight and obese patients with dengue: A matched cohort study
Background: Obesity is a risk factor for severe dengue, but underlying mechanisms remain unclear. This study compared clinical features, outcomes, and biomarkers between overweight/obese and healthy-weight patients with dengue infection. Methods: We conducted an observational matched cohort study (2019-2022) including 75 overweight/obese patients and 75 matched healthy-weight patients with dengue (by age, sex, illness phase, and inpatient ward). The primary clinical outcome was overall severity per WHO 2009 classification. Secondary outcomes included warning signs, ICU admission, fever clearance, and hospital stay. Laboratory outcomes comprised trajectories of hematology, biochemistry, and endothelial, inflammatory, and lipid biomarkers. Results: The majority of patients were enrolled on day 2-3 of illness, with DENV-2 (63.3%) as the predominant serotype and secondary infections in 93.4%. Clinical signs and symptoms at enrolment and severe dengue development (6.3% vs. 9.2%) were comparable between groups. However, the overweight/obese group developed fluid accumulation more frequently (64.1% vs. 41.5%). Laboratory profiles showed consistently higher leukocyte (∼0.55-1 K/μL), neutrophil (∼0.19-0.84 K/μL), and lymphocyte counts (∼0.04-0.28 K/μL), total cholesterol (∼0.39-0.46 mmol/L), low-density lipoprotein cholesterol (∼0.36-0.48 mmol/L), triglycerides (∼0.21-0.44 log2-mmol/L), C-reactive protein (∼0.21-0.43 log10-mg/L), ferritin (∼0.12-0.15 log10-ng/mL), and leptin (∼0.89-1 log10-ng/mL) in the overweight/obese group, alongside lower high-density lipoprotein cholesterol (∼0.06-0.23 mmol/L) and adiponectin (∼0.05-0.24 log10-ng/mL). Liver transaminases were initially higher (days 1-5) in the overweight/obese group. Conclusions: Overweight/obese patients with dengue infection display distinct clinical and immunometabolic profiles, particularly greater fluid accumulation, higher inflammatory markers and liver injury. These findings suggest obesity modifies the host response to dengue, and this patient group should be prioritized for upcoming immunomodulatory and other host-directed therapeutic trials. Author summary: Dengue is a major global health problem, and people with obesity appear to have a higher risk of developing severe disease. However, the reasons for this increased vulnerability are still poorly understood. In this study, we compared 75 overweight or obese patients with dengue to 75 patients of healthy weight who were carefully matched by age, sex, disease stage, and hospital ward. Although both groups had similar symptoms at enrollment and similar rates of severe dengue, the overweight/obese group developed fluid accumulation more often-a key sign of clinical deterioration. They also showed distinct laboratory patterns throughout their illness. Overweight/obese patients consistently had higher levels of white blood cells, inflammatory markers, liver enzymes, and lipid measures, as well as higher leptin and lower adiponectin, two hormones linked to metabolic health. These findings suggest that excess body weight alters the body’s immune and metabolic response to dengue infection, even when outward symptoms appear comparable. Understanding these differences is important because it can help clinicians identify patients at higher risk and guide the development of new treatments. Our results support prioritizing overweight and obese individuals for future trials of immunomodulatory or other host-directed therapies for dengue.
Open AccessClinical and immunometabolic profiles of overweight and obese patients with dengue: A matched cohort study
Background: Obesity is a risk factor for severe dengue, but underlying mechanisms remain unclear. This study compared clinical features, outcomes, and biomarkers between overweight/obese and healthy-weight patients with dengue infection. Methods: We conducted an observational matched cohort study (2019-2022) including 75 overweight/obese patients and 75 matched healthy-weight patients with dengue (by age, sex, illness phase, and inpatient ward). The primary clinical outcome was overall severity per WHO 2009 classification. Secondary outcomes included warning signs, ICU admission, fever clearance, and hospital stay. Laboratory outcomes comprised trajectories of hematology, biochemistry, and endothelial, inflammatory, and lipid biomarkers. Results: The majority of patients were enrolled on day 2-3 of illness, with DENV-2 (63.3%) as the predominant serotype and secondary infections in 93.4%. Clinical signs and symptoms at enrolment and severe dengue development (6.3% vs. 9.2%) were comparable between groups. However, the overweight/obese group developed fluid accumulation more frequently (64.1% vs. 41.5%). Laboratory profiles showed consistently higher leukocyte (∼0.55-1 K/μL), neutrophil (∼0.19-0.84 K/μL), and lymphocyte counts (∼0.04-0.28 K/μL), total cholesterol (∼0.39-0.46 mmol/L), low-density lipoprotein cholesterol (∼0.36-0.48 mmol/L), triglycerides (∼0.21-0.44 log2-mmol/L), C-reactive protein (∼0.21-0.43 log10-mg/L), ferritin (∼0.12-0.15 log10-ng/mL), and leptin (∼0.89-1 log10-ng/mL) in the overweight/obese group, alongside lower high-density lipoprotein cholesterol (∼0.06-0.23 mmol/L) and adiponectin (∼0.05-0.24 log10-ng/mL). Liver transaminases were initially higher (days 1-5) in the overweight/obese group. Conclusions: Overweight/obese patients with dengue infection display distinct clinical and immunometabolic profiles, particularly greater fluid accumulation, higher inflammatory markers and liver injury. These findings suggest obesity modifies the host response to dengue, and this patient group should be prioritized for upcoming immunomodulatory and other host-directed therapeutic trials. Author summary: Dengue is a major global health problem, and people with obesity appear to have a higher risk of developing severe disease. However, the reasons for this increased vulnerability are still poorly understood. In this study, we compared 75 overweight or obese patients with dengue to 75 patients of healthy weight who were carefully matched by age, sex, disease stage, and hospital ward. Although both groups had similar symptoms at enrollment and similar rates of severe dengue, the overweight/obese group developed fluid accumulation more often-a key sign of clinical deterioration. They also showed distinct laboratory patterns throughout their illness. Overweight/obese patients consistently had higher levels of white blood cells, inflammatory markers, liver enzymes, and lipid measures, as well as higher leptin and lower adiponectin, two hormones linked to metabolic health. These findings suggest that excess body weight alters the body’s immune and metabolic response to dengue infection, even when outward symptoms appear comparable. Understanding these differences is important because it can help clinicians identify patients at higher risk and guide the development of new treatments. Our results support prioritizing overweight and obese individuals for future trials of immunomodulatory or other host-directed therapies for dengue.
- 23 October 2025
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 67 (11)
Long-Term Incidence and Risk Factors of Subaortic Pannus Overgrowth After Bileaflet Mechanical Aortic Valve Replacement
Objectives: Subaortic pannus overgrowth is a recognized complication following aortic valve replacement (AVR) with mechanical prostheses, potentially requiring reoperation. Since data on its incidence and risk factors remain scarce, this study aimed to determine the incidence and risk factors for subaortic pannus overgrowth after AVR with bileaflet mechanical valves. Methods: We retrospectively analysed 1145 patients who underwent AVR with bileaflet mechanical valves between 1995 and 2010 at a cardiac referral centre. Subaortic pannus overgrowth was defined by imaging evidence causing clinical stenosis and confirmed intraoperatively. Cumulative incidence was estimated using competing risks analysis, and risk factors were identified using Fine and Gray models. Results: During a mean follow-up of 16.5 years, 47 patients (4.1%) developed subaortic pannus overgrowth requiring reoperation (mean interval 13.6 years). The 10- and 20-year cumulative incidence was 1.1% and 5.0%, respectively. Multivariable analysis identified female sex (hazard ratio [HR]: 2.18), smaller prosthetic valve size (21 mm vs ≥23 mm, HR: 8.62, and ≤19 mm vs ≥23 mm, HR: 12.02), and concomitant mitral valve replacement (HR: 2.63) as independent risk factors. Older age at AVR was protective (HR: 0.69 per 10-year increase). Recurrence occurred in 1 patient after isolated pannus resection. Conclusions: Subaortic pannus overgrowth is a late complication after bileaflet mechanical AVR, with a gradually increasing incidence. Female sex, smaller prosthesis size, younger age, and concomitant mitral valve replacement are significant risk factors. Complete pannus removal and valve replacement should be considered during reoperation. Further research into the underlying mechanisms is warranted for prevention strategies.
- 23 October 2025
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 67 (11)
Long-Term Incidence and Risk Factors of Subaortic Pannus Overgrowth After Bileaflet Mechanical Aortic Valve Replacement
Objectives: Subaortic pannus overgrowth is a recognized complication following aortic valve replacement (AVR) with mechanical prostheses, potentially requiring reoperation. Since data on its incidence and risk factors remain scarce, this study aimed to determine the incidence and risk factors for subaortic pannus overgrowth after AVR with bileaflet mechanical valves. Methods: We retrospectively analysed 1145 patients who underwent AVR with bileaflet mechanical valves between 1995 and 2010 at a cardiac referral centre. Subaortic pannus overgrowth was defined by imaging evidence causing clinical stenosis and confirmed intraoperatively. Cumulative incidence was estimated using competing risks analysis, and risk factors were identified using Fine and Gray models. Results: During a mean follow-up of 16.5 years, 47 patients (4.1%) developed subaortic pannus overgrowth requiring reoperation (mean interval 13.6 years). The 10- and 20-year cumulative incidence was 1.1% and 5.0%, respectively. Multivariable analysis identified female sex (hazard ratio [HR]: 2.18), smaller prosthetic valve size (21 mm vs ≥23 mm, HR: 8.62, and ≤19 mm vs ≥23 mm, HR: 12.02), and concomitant mitral valve replacement (HR: 2.63) as independent risk factors. Older age at AVR was protective (HR: 0.69 per 10-year increase). Recurrence occurred in 1 patient after isolated pannus resection. Conclusions: Subaortic pannus overgrowth is a late complication after bileaflet mechanical AVR, with a gradually increasing incidence. Female sex, smaller prosthesis size, younger age, and concomitant mitral valve replacement are significant risk factors. Complete pannus removal and valve replacement should be considered during reoperation. Further research into the underlying mechanisms is warranted for prevention strategies.
- Open Access
- 8 October 2025
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 12 (11) , ofaf632
Persistent Subclinical Inflammation and Long-term Functional and Cognitive Outcomes After Dengue Shock and Septic Shock in Vietnam
Background: There have been no studies reporting functional, cognitive, inflammatory or endothelial outcomes after dengue shock (DS), or septic shock (SS) in Vietnam. Methods: We conducted a prospective observational study to follow-up adult survivors of DS and SS. At hospital discharge, 1-, 3-, and 6-month follow-up, we measured health-related quality of life (EQ-5D-5L), cognitive function (Montreal Cognitive Assessment, MoCA), endothelial function (EndoPAT), and plasma biomarkers of inflammation (ferritin, IL-6, CRP) and endothelial activation (Ang1, Ang2, VCAM-1). Results: Participants included survivors of DS (n = 130), SS (n = 26), and healthy controls (n = 25). Survivors of DS had median EQ-5D-5L visual analogue score (VAS) > 90/100 at all time-points, and mildly impaired MoCA scores at hospital discharge, which had normalized by 3 months (normal ≥ 26, median [25th;75th centile] 23/30 [20;26] at discharge, 27/30 [25;29] by 3 months). Survivors of SS had lower median EQ-5D-5L VAS at all time-points (median [25th;75th centile] 80/100 [70;95] at discharge, and 90/100 [80;95] by 6 months), but MoCA scores never returned above the normal threshold (median 17/30 [13;19] at discharge, 20/30 [17;21] at 6 months). We found higher IL-6 and ferritin at all post-discharge time points in both DS and SS groups versus healthy controls (P < .01 for all comparisons). After 6 months, 38% with DS and 62% with SS still had ferritin levels >95th percentile of the healthy control distribution. There was little evidence of simultaneous endothelial activation. Conclusions: This is the first report of persistent subclinical inflammation after DS, and SS in Vietnam; further research is required to determine the duration and clinical significance of this phenomenon.
- 8 October 2025
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 12 (11) , ofaf632
Open AccessPersistent Subclinical Inflammation and Long-term Functional and Cognitive Outcomes After Dengue Shock and Septic Shock in Vietnam
Background: There have been no studies reporting functional, cognitive, inflammatory or endothelial outcomes after dengue shock (DS), or septic shock (SS) in Vietnam. Methods: We conducted a prospective observational study to follow-up adult survivors of DS and SS. At hospital discharge, 1-, 3-, and 6-month follow-up, we measured health-related quality of life (EQ-5D-5L), cognitive function (Montreal Cognitive Assessment, MoCA), endothelial function (EndoPAT), and plasma biomarkers of inflammation (ferritin, IL-6, CRP) and endothelial activation (Ang1, Ang2, VCAM-1). Results: Participants included survivors of DS (n = 130), SS (n = 26), and healthy controls (n = 25). Survivors of DS had median EQ-5D-5L visual analogue score (VAS) > 90/100 at all time-points, and mildly impaired MoCA scores at hospital discharge, which had normalized by 3 months (normal ≥ 26, median [25th;75th centile] 23/30 [20;26] at discharge, 27/30 [25;29] by 3 months). Survivors of SS had lower median EQ-5D-5L VAS at all time-points (median [25th;75th centile] 80/100 [70;95] at discharge, and 90/100 [80;95] by 6 months), but MoCA scores never returned above the normal threshold (median 17/30 [13;19] at discharge, 20/30 [17;21] at 6 months). We found higher IL-6 and ferritin at all post-discharge time points in both DS and SS groups versus healthy controls (P < .01 for all comparisons). After 6 months, 38% with DS and 62% with SS still had ferritin levels >95th percentile of the healthy control distribution. There was little evidence of simultaneous endothelial activation. Conclusions: This is the first report of persistent subclinical inflammation after DS, and SS in Vietnam; further research is required to determine the duration and clinical significance of this phenomenon.
- 3 September 2025
- Published by Wolters Kluwer Health in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
- Vol. 35 (6)
Minimally Invasive Left Colonic Interposition For Corrosive Esophageal Stricture: Technique and Outcomes
Background: Corrosive ingestion frequently leads to upper aerodigestive tract strictures, with the optimal surgical approach debated. This study investigates the safety and effectiveness of colonic interposition for this condition. Methods: We retrospectively reviewed 21 patients with corrosive-induced esophageal stricture who underwent left colonic interposition between 2017 and 2024. Procedures involved cervical dissection, colonic mobilization, retrosternal tunnel creation, and reconstruction. Four patients underwent fully open surgical procedures, and 17 patients underwent laparoscopic colon mobilization and retrosternal tunnel creation. Outcomes included surgical complications and short-term and long-term feeding function. Results: The mean age was 37 years, with a male predominance (14/21 patients). All had esophageal stricture secondary to chemical burn for >1 year, and 14 were malnourished. Stricture locations were cervical (5 patients), upper third (8 patients), middle third (8 patients), and lower third (3 patients). Laparoscopic surgery had longer mean operative times than open surgery (361 vs. 294 min). One patient developed gastric outlet obstruction due to an undiagnosed pyloric stenosis. All patients resumed oral feeding by postoperative day 2, and feeding jejunostomy were removed at 1 month. During a median 30-month follow-up, all maintained normal oral intake and survived. Conclusions: Left colonic graft interposition for esophageal reconstruction in caustic strictures is safe and effective. However, the technique is complex, particularly laparoscopically. Adequate graft length, vascularity, and isoperistaltic anastomosis are crucial for success.
- 3 September 2025
- Published by Wolters Kluwer Health in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
- Vol. 35 (6)
Minimally Invasive Left Colonic Interposition For Corrosive Esophageal Stricture: Technique and Outcomes
Background: Corrosive ingestion frequently leads to upper aerodigestive tract strictures, with the optimal surgical approach debated. This study investigates the safety and effectiveness of colonic interposition for this condition. Methods: We retrospectively reviewed 21 patients with corrosive-induced esophageal stricture who underwent left colonic interposition between 2017 and 2024. Procedures involved cervical dissection, colonic mobilization, retrosternal tunnel creation, and reconstruction. Four patients underwent fully open surgical procedures, and 17 patients underwent laparoscopic colon mobilization and retrosternal tunnel creation. Outcomes included surgical complications and short-term and long-term feeding function. Results: The mean age was 37 years, with a male predominance (14/21 patients). All had esophageal stricture secondary to chemical burn for >1 year, and 14 were malnourished. Stricture locations were cervical (5 patients), upper third (8 patients), middle third (8 patients), and lower third (3 patients). Laparoscopic surgery had longer mean operative times than open surgery (361 vs. 294 min). One patient developed gastric outlet obstruction due to an undiagnosed pyloric stenosis. All patients resumed oral feeding by postoperative day 2, and feeding jejunostomy were removed at 1 month. During a median 30-month follow-up, all maintained normal oral intake and survived. Conclusions: Left colonic graft interposition for esophageal reconstruction in caustic strictures is safe and effective. However, the technique is complex, particularly laparoscopically. Adequate graft length, vascularity, and isoperistaltic anastomosis are crucial for success.